Vise Technologies Inc. Makes New $2.55 Million Investment in Danaher Corporation $DHR

Vise Technologies Inc. purchased a new position in shares of Danaher Corporation (NYSE:DHR) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 13,406 shares of the conglomerate’s stock, valued at approximately $2,554,000.

Several other hedge funds also recently modified their holdings of the business. Northwestern Mutual Wealth Management Co. lifted its position in shares of Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after acquiring an additional 186,584 shares during the period. Puzo Michael J bought a new stake in shares of Danaher during the second quarter valued at approximately $8,624,000. Legal & General Group Plc raised its stake in shares of Danaher by 1.0% in the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after purchasing an additional 43,169 shares in the last quarter. Handelsbanken Fonder AB lifted its position in Danaher by 10.9% in the second quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock worth $55,091,000 after purchasing an additional 28,425 shares during the period. Finally, Advisors Capital Management LLC lifted its position in Danaher by 14.0% in the fourth quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock worth $12,555,000 after purchasing an additional 6,720 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

Danaher stock opened at $219.42 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock has a fifty day moving average price of $195.80 and a two-hundred day moving average price of $192.61. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.69 and a beta of 0.78.

Danaher (NYSE:DHR) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the previous year, the company earned $0.77 EPS. The firm’s revenue for the quarter was up 5.5% compared to the same quarter last year. As a group, analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on DHR. Argus lowered their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Friday, April 24th. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Wells Fargo & Company lowered their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Finally, Stifel Nicolaus dropped their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.